March 30, 2022
PAR-22-139 - Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
PAR-22-140 - Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The National Cancer Institute (NCI) will hold a public pre-application webinar on April 14, 2022, at 3:00 - 5:00 pm EDT.
NCI staff members involved in managing this program will assist potential applicants by explaining the goals and objectives of this initiative and answering questions from attendees. Prospective applicants are encouraged to submit their questions or comments to firstname.lastname@example.org in advance of the webinar.
Registration: Potential applicants interested in participating in the webinar should send an email to:
Ms. Julie Hong (Hongj@mail.nih.gov) to obtain registration information no later than 5:00 p.m. (EDT) April 07, 2022.
Please include "NCI Assistance Webinar for STRIPE RFA” in the subject line of the email.